Experience

Davis Polk is acting as special tax counsel to Pfizer Inc. on the combination of its off-patent branded and generic established medicines business, Upjohn, with Mylan N.V. Under the terms…

Davis Polk is advising an ad hoc group of prepetition term loan lenders and initial debtor-in-possession financing lenders in the chapter 11 restructuring of Philadelphia Energy Solutions…

Davis Polk advised the administrative agent and certain revolving lenders under Crossmark Holdings, Inc.’s first-lien credit agreement in connection with the out-of-court restructuring of…

Davis Polk advised the joint bookrunners in connection with a Rule 144A/Regulation S offering by Imperial Brands Finance PLC of $2.75 billion aggregate principal amount of notes guaranteed…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering of common stock by Seattle Genetics, Inc. for gross…

Davis Polk advised the initial purchasers in connection with a $320 million Regulation S offering by China Oil and Gas Group Limited of its 5.5% senior notes due 2023. China Oil and Gas…

Davis Polk is advising The Charles Schwab Corporation on its $1.8 billion acquisition of assets of USAA’s Investment Management Company, including brokerage and managed portfolio accounts…

Davis Polk advised the underwriters in connection with Synchrony Financial’s SEC-registered offering of $750 million aggregate principal amount of 2.850% senior notes due 2022. Based…

Davis Polk advised the initial purchasers in connection with a $300 million Regulation S offering by CIFI Holdings (Group) Co. Ltd. of its 6.55% senior notes due 2024. The notes are…

Davis Polk advised the initial purchaser in connection with a CNY1.6 billion Regulation S offering by CIFI Holdings (Group) Co. Ltd. of its 6.70% senior notes due 2022. Established in 2000…